These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
74 related items for PubMed ID: 3016495
1. [An in vitro sensitivity assay for anti-cancer agents by measuring the inhibition rate of DNA synthesis (3H-thymidine uptake of cancer cells). II. Clinical study of 110 cases of breast cancer]. Nio Y, Ohgaki K, Inamoto T, Kan N, Kodama H, Tobe T. Nihon Geka Gakkai Zasshi; 1986 Jun; 87(6):680-96. PubMed ID: 3016495 [Abstract] [Full Text] [Related]
2. Anticancer chemosensitivity profiles of human breast cancer cells assessed by in vitro DNA synthesis inhibition assay. Nio Y, Tamura K, Kan N, Inamoto T, Ohgaki K, Kodama H. Anticancer Res; 2000 Jun; 20(2B):1237-44. PubMed ID: 10810427 [Abstract] [Full Text] [Related]
3. [An in vitro sensitivity assay of anti-cancer agents by measuring the inhibition rate of DNA synthesis (3H-thymidine uptake) of cancer cells--clinical study]. Nio Y, Inamoto T, Ohgaki K, Kan N, Hori T, Nakayama N, Yamasaki N, Hikasa Y. Nihon Geka Gakkai Zasshi; 1985 Jan; 86(1):8-22. PubMed ID: 3974569 [Abstract] [Full Text] [Related]
4. Anticancer chemosensitivity and growth rate of freshly separated human colorectal cancer cells assessed by in vitro DNA synthesis inhibition assay. Kawabata K, Nio Y, Imamura M, Fukumoto M. Anticancer Res; 1998 Jan; 18(3A):1633-40. PubMed ID: 9673382 [Abstract] [Full Text] [Related]
5. Acquisition of multidrug resistance in recurrent breast cancer demonstrated by the histoculture drug response assay. Tanino H, Oura S, Hoffman RM, Kubota T, Furukawa T, Arimoto J, Yoshimasu T, Hirai I, Bessho T, Suzuma T, Sakurai T, Naito Y. Anticancer Res; 2001 Jan; 21(6A):4083-6. PubMed ID: 11911296 [Abstract] [Full Text] [Related]
6. [Systemic chemotherapy of mammary carcinoma: plasma and tissue concentrations of 5-fluorouracil and adriamycin, and result of CAF and CMF therapy of breast cancer]. Murayama Y, Nagashima M. Gan To Kagaku Ryoho; 1984 Mar; 11(3):415-9. PubMed ID: 6546655 [Abstract] [Full Text] [Related]
7. [Chemosensitivity test for 170 human breast carcinoma samples]. He Z, Yuan J, Chen Z, Liu S, Shen Z, Fei H. Hunan Yi Ke Da Xue Xue Bao; 1998 Mar; 23(6):531-4. PubMed ID: 10806759 [Abstract] [Full Text] [Related]
8. In vitro DNA synthesis in freshly separated human breast cancer cells assessed by tritiated thymidine incorporation assay: relationship to the long-term outcome of patients. Nio Y, Tamura K, Kan N, Inamoto T, Ohgaki K, Kodama H. Br J Surg; 1999 Nov; 86(11):1463-9. PubMed ID: 10583297 [Abstract] [Full Text] [Related]
9. In vivo inhibitory effect of anticancer agents on human pancreatic cancer xenografts transplanted in nude mice. Imai S, Nio Y, Shiraishi T, Manabe T, Tobe T. Anticancer Res; 1991 Nov; 11(2):657-64. PubMed ID: 2064319 [Abstract] [Full Text] [Related]
10. Randomized trial of cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil with node-positive breast cancer in Japan. Kimura M, Tominaga T, Takatsuka Y, Toi M, Abe R, Koyama H, Takashima S, Nomura Y, Miura S, Kimijima I, Tashiro H, Ohashi Y, Adjuvant CEF Research Group for Breast Cancer. Breast Cancer; 2010 Jul; 17(3):190-8. PubMed ID: 19575284 [Abstract] [Full Text] [Related]
11. Chemosensitivity correlation between the primary tumors and simultaneous metastatic lymph nodes of patients evaluated by DNA synthesis inhibition assay. Nio Y, Imai S, Shiraishi T, Tsubono M, Morimoto H, Tseng CC, Tobe T. Cancer; 1990 Mar 15; 65(6):1273-8. PubMed ID: 2106383 [Abstract] [Full Text] [Related]
12. Chemosensitivity testing of human lung cancer tissues using the succinate dehydrogenase inhibition test. Mitsudomi T, Kaneko S, Tateishi M, Yano T, Ishida T, Kohnoe S, Maehara Y, Sugimachi K. Anticancer Res; 1990 Mar 15; 10(4):987-90. PubMed ID: 2382998 [Abstract] [Full Text] [Related]
13. [Phase II study of peplomycin in breast cancer. A cooperative study. Clinical Study Group of Peplomycin for Breast Cancer in Japan]. Kousaki G, Tominaga T, Uchino J, Hata H, Hayasaka A, Asaishi K, Kimura M, Abe O, Enomoto K, Watanabe H. Gan To Kagaku Ryoho; 1987 Jul 15; 14(7):2347-51. PubMed ID: 2440387 [Abstract] [Full Text] [Related]
14. Paclitaxel as a first-line chemotherapy for Japanese women with advanced or recurrent breast cancer: a multi-institutional practice-based study by the Kyushu Breast Cancer Study Group (KBC-SG). Ishikawa M, Takamatsu Y, Mitsuyama S, Iwakuma N, Anan K, Umeda S, Tamura K. Breast Cancer; 2010 Apr 15; 17(2):131-5. PubMed ID: 19472037 [Abstract] [Full Text] [Related]
15. [Clinical evaluation of intra-arterial infusion chemotherapy for advanced or recurrent cervical cancer with or without radiotherapy]. Kaneyasu Y, Okawa MK, Kokubo N, Karasawa K, Fukuhara N, Toda J, Okawa T. Gan To Kagaku Ryoho; 1997 Sep 15; 24(12):1813-6. PubMed ID: 9382539 [Abstract] [Full Text] [Related]
16. Lymphocytes anticancer chemosensitivity testing in vitro--an approach to predict immunosuppressive effect of anticancer agents. Nio Y, Imai S, Shiraishi T, Ohgaki K, Tobe T. J Clin Lab Immunol; 1989 Jul 15; 29(3):141-5. PubMed ID: 2517429 [Abstract] [Full Text] [Related]
17. [Clinical studies on a rapid screening assay for anticancer agents with nude mice and isotopic evaluation]. Nosoh Y, Nishiyama M, Yamaguchi M, Hirabayashi N, Toge T, Niimoto M, Hattori T. Gan To Kagaku Ryoho; 1986 Apr 15; 13(4 Pt 2):1221-6. PubMed ID: 3729445 [Abstract] [Full Text] [Related]
18. An anticancer drug sensitivity test to determine the effectiveness of UFT as postoperative adjuvant chemotherapy for patients with stage III colorectal cancer. Isogai A, Nagaya M, Matsuoka H, Watanabe T, Tsukikawa S, Kubota S. Surgery; 2007 Nov 15; 142(5):741-8. PubMed ID: 17981195 [Abstract] [Full Text] [Related]
19. [Human tumor clonogenic assay in human breast cancer]. Kobayashi T, Kuraishi Y, Aiba K, Inoue K. Gan To Kagaku Ryoho; 1985 Aug 15; 12(8):1566-72. PubMed ID: 3927846 [Abstract] [Full Text] [Related]
20. Chemosensitivity differences between primary and metastatic lesions of clinical gastric cancer. Kusumoto H, Maehara Y, Kusumoto T, Anai H, Akazawa K, Sugimachi K. Eur J Surg Oncol; 1988 Dec 15; 14(6):685-9. PubMed ID: 3192005 [Abstract] [Full Text] [Related] Page: [Next] [New Search]